News: Boston Scientific Corp (BSX)

BSX on New York Consolidated

16.76USD
3 Mar 2015
Change (% chg)

-- (--)
Prev Close
$16.76
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
13,294,843
52-wk High
$17.26
52-wk Low
$11.10

Search Stocks
Select another date:

Mon, Mar 2 2015

Boston Scientific to buy Endo's urology portfolio for $1.65 billion

- Medical device maker Boston Scientific Corp said it will buy Endo International Plc's American Medical Systems' men's and prostate health business for up to $1.65 billion.

UPDATE 1-Boston Scientific to buy Endo's urology portfolio for $1.65 bln

March 2 - Medical device maker Boston Scientific Corp said it will buy Endo International Plc's American Medical Systems' men's and prostate health business for up to $1.65 billion.

Boston Scientific to buy Endo's urology portfolio for up to $1.65 bln

March 2 - Boston Scientific Corp said it will acquire Endo International Plc's American Medical Systems urology portfolio for up to $1.65 billion.

Deals of the day- Mergers and acquisitions

Feb 24 - The following bids, mergers, acquisitions and disposals were reported by 2100 GMT on Tuesday:

Boston Scientific near deal to buy Endo's device unit: sources

NEW YORK - Boston Scientific Corp is close to buying Endo International PLC's AMS medical device unit, a deal that could value the business at around $2 billion, according to people familiar with the matter.

Boston Scientific to pay J&J $600 million to settle Guidant suit

- Medical device maker Boston Scientific Corp on Tuesday said it has agreed to pay $600 million to Johnson & Johnson to settle a long-running lawsuit over Boston Scientific's 2005 acquisition of rival Guidant.

Boston Scientific to pay J&J $600 million to settle Guidant suit

- Medical device maker Boston Scientific Corp on Tuesday said it has agreed to pay $600 million to Johnson & Johnson to settle a long-running lawsuit over Boston Scientific's 2005 acquisition of rival Guidant.

UPDATE 1-Boston Scientific to pay J&J $600 mln to settle Guidant suit

Feb 17 - Medical device maker Boston Scientific Corp on Tuesday said it has agreed to pay $600 million to Johnson & Johnson to settle a long-running lawsuit over Boston Scientific's 2005 acquisition of rival Guidant.

Fitch: Boston Scientific's Settlement Reduces Liability Risk but Also Liquidity

(The following statement was released by the rating agency) CHICAGO, February 17 (Fitch) Boston Scientific Corp.'s (NYSE: BSX) ratings are unaffected by its recent settlement with Johnson & Johnson (NYSE: JNJ) regarding litigation associated with BSX's acquisition of Guidant in 2006, according to Fitch Ratings. The settlement calls for BSX to pay $600 million to JNJ during 2015. BSX will make two $300 million dollar payments, primarily using balance sheet cash without taking on any additio

Boston Scientific to pay J&J $600 mln to settle Guidant suit

- Medical device maker Boston Scientific Corp on Tuesday said it has agreed to pay $600 million to Johnson & Johnson to settle a long-running breach of merger lawsuit over Boston Scientific's 2005 acquisition of rival Guidant.

Select another date:
Search Stocks